Industry Insights on Contraceptives Market| Top Players: Allergan, Actavis plc, Bayer, CooperSurgical, Church & Dwight Co., Inc., Merck, Pfizer

The Contraceptives Market is set to exceed USD 38,500.5 million by 2025; according to a new research study published by Global Market Insights, Inc. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population will create huge demand for contraceptives during the forecast period. Various programs aiming to meet the need for modern contraception and provide reproductive and sexual health services should involve a good participation of women, adolescents, and young people, at all stages of planning, implementation, and evaluation.

An increasing number of women are postponing motherhood as they prioritize their careers. Moreover, balancing concerns of the cost for raising a child, ambiguity over job safety and unstable relationships are increasingly causing women to postpone pregnancy. In 2015, globally 64% of in-union or married women of fertile age were using some mode of contraception. Nevertheless, contraceptive use was much lesser in the under developed countries and was particularly low in Africa where only 33% of women are projected to use the products so far. High unmet needs in developing nation will fuel the Contraceptives Market size. Demand for contraceptives would rise owing to rising numbers of new HIV infections in many countries over the coming years

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/430

Oral contraceptive pills market is estimated to witness significant growth at 4.9% over the forecast period owing to factors such as most effective method of birth control, daily consumption resulting in reduced cramping during periods, enabling acne reduction and minimized risk of developing cervical & endometrial cancers. Growing use of injectable drugs that are injected under the skin and released in the bloodstream to prevent unwanted pregnancy and effective in preventing unwanted birth will drive the augmented demand for the drug.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Allergan
• Actavis plc
• Bayer
• CooperSurgical
• Church & Dwight Co., Inc.
• Merck
• Pfizer
• RECKITT BENCKISER GROUP PLC
• Teva Pharmaceuticals
• Veru Inc.

Condoms segment accounted for USD 8,622.8 million in 2018 and will grow significantly over the forecast period. Male condoms are widely used and are considered as first line of protection worldwide. Associated advantages like ease to use, affordable cost, elevated level of protection and least side effects amongst all the other devices will drive the segment growth. Furthermore, increasing demand of IUD’s owing to high degree of effectiveness and most efficacious alternatives available in female contraceptives market will offer considerable segment growth.

Citing another instance of the vital role that regulatory bodies play in the growth of contraceptives market, it is prudent to mention that recently, the Philippines Department of Health (DOH) announced that it would buy contraceptives worth 200 million pesos. Through this purchase, the government apparently aims to manufacture pills and other contraceptives in order to overcome the current shortage and fulfill the demand for family planning products in the ensuing years. The initiative undertaken by the Philippines DOH takes precedence in contraceptives market, validating the fact that the prevalence of family planning policies and government programs is likely to stimulate Asia Pacific contraceptives industry share over the years ahead.

Currently, numerous contraceptives market giants and regulatory bodies have been striving to bring about a transformation in the product landscape of this business sphere. The Food and Drug Administration (FDA) for instance, has revealed a list of 51 contraceptives for re-certification based on the parameters of safety and non-abortifaciency. Even in the U.S., the California Health Benefits Review Program (CHBRP) has enforced a federal contraceptive mandate – the Affordable Care Act (ACA). On these grounds, the Trump administration has released two interim rules related to ACA’s contraceptive coverage requirement, which would provide a boost to U.S. contraceptives market trends. Considering the strict outlook that regulatory bodies have toward newly developed products, contraceptives industry players such as Merck & Co., Pfizer, Mayer Laboratories, Cooper Surgical Inc., Teva Pharmaceutical Industries, Actavis, Reckitt Benckiser, and Church & Dwight Co. have also been heavily investing in research and development activities, thereby impelling this business sphere.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/430

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Contraceptives industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Age trends

2.1.4. Regional trends

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/contraceptives-market-report

Chapter 3. Contraceptives Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1. Growth drivers

Favorable regulatory scenario in developed nations
Growing inclination towards planned delayed pregnancy
High unmet contraceptive needs in developing economies
Growing prevalence of Sexually Transmitted Diseases (STD) in African region

3.3.2. Industry pitfalls & challenges

Growing infertility prevalence
Adverse effects of contraceptive drugs

Data Tables

1 Contraceptives industry 3600 synopsis, 2014 – 2025
2 Global contraceptives market, 2014 – 2018 (USD Million)
3 Global contraceptives market, 2019 – 2025 (USD Million)
4 Global contraceptives market, by product, 2014 - 2018 (USD Million)
5 Global contraceptives market, by product, 2019 - 2025 (USD Million)
6 Global contraceptives market, by age, 2014 - 2018 (USD Million)
7 Global contraceptives market, by age, 2019 - 2025 (USD Million)
8 Global contraceptives market, by region, 2014 – 2018 (USD Million)
9 Global contraceptives market, by region, 2019 – 2025 (USD Million)
10 Industry impact forces

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.